Replimune Group, Inc. - Common Stock (NQ:REPL)All News about Replimune Group, Inc. - Common Stock
Replimune Announces Type A Meeting Scheduled with FDA
September 02, 2025
From Replimune, Inc.
Via GlobeNewswire
Via NewMediaWire
Topics
Lawsuit
Via NewMediaWire
Topics
Lawsuit
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|